Company intelligence / Profile preview

International Institute for the Advancement of Medicine

Edison, New Jersey, United Statesiiam.org ↗

Ownership: Private
Employees: ~26
Development stage: Other

Overview

IIAM is a leading global provider of non-transplantable human organs and tissues, supporting medical research, education, and development. It collaborates with organ procurement organizations, tissue banks, donor families, and researchers to facilitate access to biomaterials that accelerate drug development and disease understanding. Its Neonatal Donor Program enables families facing fatal fetal diagnoses to contribute to vital medical research.

Modalities: Human organ and tissue supply (for research, not direct therapeutic modalities)
Industry: Drug Discovery Services

Partnerships

Organovo HoldingsVarious academic institutions/researchers globally

Beyond the preview

Go deeper on International Institute for the Advancement of Medicine.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on International Institute for the Advancement of Medicine.

Explore the full profile